1990-2021年中国归因于高低密度脂蛋白胆固醇的心血管疾病负担及趋势预测OA
Cardiovascular disease burden attributed to high low-density lipoprotein cholesterol in China from 1990 to 2021 and trend prediction
目的 分析 1990-2021 年中国归因于高低密度脂蛋白胆固醇(LDL-C)的心血管疾病(CVD)负担变化趋势并进行预测分析.方法 基于2021年全球疾病负担研究数据库,采用Joinpoint回归分析归因于高LDL-C的CVD疾病变化趋势,年龄-时期-队列模型探讨年龄、时期、队列效应.ARIMA模型预测 2022-2031 年归因于高LDL-C的CVD疾病负担趋势.结果 2021 年归因于高LDL-C的CVD伤残调整寿命年(DALY)为 1 840.77 万人年,死亡人数为 83.28 万人.1990-2021 年归因于高LDL-C的CVD的年龄标准化DALY率(ASDR)无明显变化趋势[AAPC=-0.15%,95%CI(-0.35%,0.05%)],缺血性心脏病ASDR无明显变化趋势[AAPC=0.06%,95%CI(-0.18%,0.30%)],缺血性脑卒中ASDR呈下降趋势[AAPC=-0.46%,95%CI(-0.63%,-0.29%)].1990-2021 年归因于高LDL-C的CVD的年龄标准化死亡率(ASMR)无明显变化趋势[AAPC=0.11%,95%CI(-0.19%,0.42%)],缺血性心脏病ASMR呈上升趋势[AAPC=0.47%,95%CI(0.18%,0.76%)],缺血性脑卒中ASMR呈下降趋势[AAPC=-0.42%,95%CI(-0.66%,-0.18%)].2021 年归因于高LDL-C的CVD疾病负担随年龄增长呈指数上升趋势;男性疾病负担高于女性.年龄效应显示,归因于高LDL-C的CVD、缺血性心脏病、缺血性脑卒中DALY率和死亡率随年龄增长而上升.时期效应显示,归因于高LDL-C的CVD、缺血性心脏病、缺血性脑卒中DALY风险与死亡风险均呈现先上升后下降的趋势.队列效应显示,出生越晚的队列其DALY风险与死亡风险越低.ARIMA模型预测显示,2022-2031 年归因于高LDL-C的CVD整体负担上升,但缺血性脑卒中负担下降.结论 1990―2021 年中国归因于高LDL-C的CVD整体疾病负担无明显变化趋势,而缺血性心脏病、缺血性脑卒中亚组疾病负担变化趋势存在差异,CVD疾病负担随年龄增长而加重,男性疾病负担高于女性.ARIMA预测模型显示,2022-2031 年归因于高LDL-C的CVD整体疾病负担上升,主要由缺血性心脏病驱动,而缺血性脑卒中负担持续下降.
Objective To analyze and predict the changing trends of cardiovascular disease(CVD)burden attributable to high low-density lipoprotein cholesterol(LDL-C)in China from 1990 to 2021.Methods Based on the Global Burden of Disease 2021 database,Joinpoint regression analysis was used to analyze the changing trends of CVD attributable to high LDL-C.An age-period-cohort model was used to explore the effects of age,period,and cohort.An ARIMA model was used to predict the CVD burden trend attributable to high LDL-C from 2022 to 2031.Results In 2021,the disability-adjusted life year(DALY)of CVD attributable to high LDL-C was 18,407,700 person-years,with 832,800 deaths.From 1990 to 2021,there was no significant trend in the age-standardized DALYs rate(ASDR)of CVD attributable to high LDL-C[AAPC=-0.15%,95%CI(-0.35%,0.05%)].There was no significant trend in ASDR in the ischemic heart disease subgroup[AAPC=0.06%,95%CI(-0.18%,0.30%)].The ASDR in the ischemic stroke subgroup showed a decreasing trend[AAPC=-0.46%,95%CI(-0.63%,-0.29%)].Age-standardized mortality rate(ASMR)attributable to high LDL-C CVD showed no clear trend from 1990 to 2021[AAPC=0.11%,95%CI(-0.19%,0.42%)].The ASMR in the ischemic heart disease subgroup showed an increasing trend[AAPC=0.47%,95%CI(0.18%,0.76%)],while the ASMR in the ischemic stroke subgroup showed a decreasing trend[AAPC=-0.42%,95%CI(-0.66%,-0.18%)].In 2021,the CVD burden attributable to high LDL-C increased exponentially with age.The disease burden was higher in men than in women.The age effect showed that the rates of DALYs and mortality from CVD attributable to high LDL-C,ischemic heart disease,and ischemic stroke,increased with age.The period effect showed that the risks of DALYs and mortality from CVD,ischemic heart disease,and ischemic stroke attributable to high LDL-C all initially increased and then decreased.The cohort effect showed that later birth cohorts had lower risks of DALYs and mortality.The ARIMA model predicts that the overall CVD burden attributable to high LDL-C will increase from 2022 to 2031,but that of ischemic stroke will decrease.Conclusion From 1990 to 2021,the overall CVD disease burden attributable to high LDL-C in China showed no significant trend,while the disease burden trends differed between ischemic heart disease and ischemic stroke subgroups.The burden increased with age,and the disease burden was higher in males than in females.The ARIMA model predicts that from 2022 to 2031,the overall CVD disease burden attributable to high LDL-C will increase,mainly driven by ischemic heart disease,while the ischemic stroke burden will continue to decline.
阿力木·卡特尔;沙吉旦·阿不都热衣木;迪丽达尔·希力甫
新疆医科大学第一附属医院老年医学科(乌鲁木齐 830011)新疆医科大学第一附属医院综合内三科(乌鲁木齐 830011)新疆医科大学第一附属医院心脏重症监护室(乌鲁木齐 830011)
医药卫生
心血管疾病低密度脂蛋白胆固醇缺血性脑卒中缺血性心脏病疾病负担危险因素预测
Cardiovascular diseaseLow-density lipoprotein cholesterolIschemic strokeIschemic heart diseaseDisease burdenRisk factorsPrediction
《医学新知》 2026 (2)
161-168,8
新疆维吾尔自治区卫生健康保健科研专项项目(BL202615)"天山英才"医药卫生高层次人才培养项目(TSYC202301B075)
评论